Dose-escalation Study of Lupartumab Amadotin (BAY1129980)
Clinical trial NCT02134197 · TERMINATED
Trial details
- NCT number
- NCT02134197
- Sponsor
- Bayer
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-05-22
- Primary completion
- 2018-08-30
- Enrollment
- 69
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.